Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antiphospholipid Syndrome | 5 | 2021 | 173 | 1.890 |
Why?
|
| Polypharmacy | 2 | 2021 | 294 | 1.260 |
Why?
|
| Antibodies, Antiphospholipid | 3 | 2021 | 69 | 0.750 |
Why?
|
| Coronary Stenosis | 1 | 2023 | 834 | 0.600 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 850 | 0.470 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.410 |
Why?
|
| Heart Failure | 4 | 2023 | 10895 | 0.360 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2021 | 2104 | 0.360 |
Why?
|
| Endoscopy | 2 | 2015 | 1787 | 0.330 |
Why?
|
| Lymphocytes | 1 | 2016 | 2617 | 0.320 |
Why?
|
| Mitral Valve | 1 | 2016 | 1491 | 0.300 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 952 | 0.270 |
Why?
|
| Neutrophils | 1 | 2016 | 3721 | 0.230 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6486 | 0.230 |
Why?
|
| Databases, Factual | 1 | 2019 | 7730 | 0.230 |
Why?
|
| Intestinal Perforation | 2 | 2015 | 253 | 0.220 |
Why?
|
| Breast Neoplasms | 4 | 2017 | 20824 | 0.210 |
Why?
|
| Thrombosis | 1 | 2016 | 2968 | 0.210 |
Why?
|
| Hospitalization | 2 | 2023 | 10259 | 0.200 |
Why?
|
| Phenotype | 1 | 2019 | 16367 | 0.190 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2021 | 142 | 0.180 |
Why?
|
| Stroke | 2 | 2019 | 9981 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2023 | 15078 | 0.140 |
Why?
|
| Catastrophic Illness | 1 | 2017 | 57 | 0.140 |
Why?
|
| Embolism | 1 | 2019 | 408 | 0.140 |
Why?
|
| Plasma Exchange | 1 | 2017 | 152 | 0.140 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2017 | 127 | 0.140 |
Why?
|
| Stomach Rupture | 1 | 2015 | 2 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 2200 | 0.130 |
Why?
|
| Duodenum | 2 | 2015 | 484 | 0.130 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 69 | 0.130 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2015 | 55 | 0.120 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 141 | 0.120 |
Why?
|
| Drug Utilization | 1 | 2020 | 1183 | 0.120 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 793 | 0.120 |
Why?
|
| Serologic Tests | 1 | 2016 | 374 | 0.120 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2015 | 80 | 0.120 |
Why?
|
| Menarche | 1 | 2017 | 516 | 0.120 |
Why?
|
| Obesity | 1 | 2015 | 12746 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1002 | 0.110 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 412 | 0.110 |
Why?
|
| Surgical Instruments | 1 | 2015 | 395 | 0.110 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 504 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2023 | 3107 | 0.100 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 2924 | 0.100 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 547 | 0.100 |
Why?
|
| Coronary Angiography | 1 | 2023 | 4576 | 0.100 |
Why?
|
| Age Factors | 2 | 2020 | 18373 | 0.100 |
Why?
|
| Anticoagulants | 4 | 2022 | 4600 | 0.100 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 5035 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1637 | 0.100 |
Why?
|
| Humans | 22 | 2023 | 744366 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2023 | 2531 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 1133 | 0.090 |
Why?
|
| Neutropenia | 1 | 2015 | 895 | 0.090 |
Why?
|
| Sirolimus | 1 | 2017 | 1565 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
| Cardiology | 1 | 2020 | 1668 | 0.090 |
Why?
|
| Brain | 1 | 2016 | 26388 | 0.080 |
Why?
|
| Aged | 7 | 2023 | 163288 | 0.080 |
Why?
|
| Menopause | 1 | 2017 | 1626 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2023 | 57776 | 0.080 |
Why?
|
| Risk Factors | 4 | 2020 | 72296 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2019 | 3461 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 1338 | 0.070 |
Why?
|
| Female | 13 | 2023 | 380193 | 0.070 |
Why?
|
| Comorbidity | 1 | 2020 | 10388 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3778 | 0.060 |
Why?
|
| Adult | 7 | 2019 | 214052 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8340 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 3070 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4153 | 0.060 |
Why?
|
| Middle Aged | 7 | 2023 | 213390 | 0.060 |
Why?
|
| Echocardiography | 1 | 2016 | 5099 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10252 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 8091 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2022 | 23336 | 0.050 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2021 | 31 | 0.050 |
Why?
|
| Warfarin | 2 | 2020 | 1497 | 0.050 |
Why?
|
| Inflammation | 1 | 2017 | 10637 | 0.040 |
Why?
|
| Pregnancy | 1 | 2019 | 29144 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2017 | 231 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 315 | 0.030 |
Why?
|
| Male | 5 | 2023 | 350115 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 53290 | 0.030 |
Why?
|
| American Heart Association | 1 | 2020 | 1057 | 0.030 |
Why?
|
| United States | 2 | 2020 | 69872 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7147 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2016 | 528 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 40075 | 0.030 |
Why?
|
| Ferritins | 1 | 2017 | 590 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 40559 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77460 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3666 | 0.020 |
Why?
|
| Rectum | 1 | 2015 | 904 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2023 | 5006 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 3914 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35425 | 0.020 |
Why?
|
| Emergencies | 1 | 2015 | 1170 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 3252 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2540 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2190 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3954 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1772 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 2535 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4851 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2417 | 0.020 |
Why?
|
| Prognosis | 2 | 2017 | 29060 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2951 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 63107 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3476 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 6755 | 0.010 |
Why?
|
| Risk | 1 | 2016 | 9688 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 20952 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20130 | 0.010 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_